Genmab A/S

Biotechnology & Medical Research

Company Summary

Genmab A/S is a Danish company that develops antibody therapies for the treatment of cancer and other disorders. Genmab A/S is based in Copenhagen, Denmark, and was formed in 1999.

ESG Rating Overview

Sustainalytics

Overall ESG Rating :

27
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
0100E0.1S19.4G7.7

Refinitiv

Overall ESG Rating :

69
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
0100E40S79G81

Overall ESG Rating :

AA
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader

Genmab is a leader among 41 companies in the biotechnology industry.

Temperature Rise :

1.64℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned